Observations concerning the natural history of subclinical hyperthyroidism
- PMID: 16053385
- DOI: 10.1089/thy.2005.15.687
Observations concerning the natural history of subclinical hyperthyroidism
Abstract
Objective: To examine the natural history of a subnormal serum thyroid-stimulating hormone (TSH) concentration with normal concentrations of both serum free thyroxine (FT4) and free triiodothyronine (FT3) (subclinical hyperthyroidism). PATIENTS, DESIGN, AND MEASUREMENTS: A retrospective analysis was undertaken and yielded 16 ambulatory patients who had presented with subclinical hyperthyroidism and were longitudinally followed with measurements of serum TSH and both FT4 and FT3 for a cumulative follow-up of 11 to 36 months. Seven of the patients had subclinical Graves' hyperthyroidism as judged from the presence of thyroid-stimulating immunoglobulins (TSI) in serum, and 9 had multinodular goiter confirmed with ultrasound and no TSI.
Results: In the 7 patients with TSI, serum TSH reverted to normal in 5 patients, with disappearance or decrease of TSI in 4, within 3 to 19 months. In 1 patient, subnormal serum TSH accompanied by both normal FT4 and FT3 has persisted for 15 months, and in a second patient serum TSH reverted to normal within 9 months, but at follow-up 27 months later overt hyperthyroidism had emerged. In the 9 patients with multinodular goiter, subnormal serum TSH accompanied by both normal FT4 and FT3 persisted during cumulative follow-up that ranged from 11 to 36 months.
Conclusions: This study suggests that the natural history of subclinical hyperthyroidism is variable, resolving or occasionally evolving in subclinical Graves' disease and persisting unchanged in multinodular goiter.
Similar articles
-
Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.J Clin Endocrinol Metab. 2000 Nov;85(11):4157-61. doi: 10.1210/jcem.85.11.6979. J Clin Endocrinol Metab. 2000. PMID: 11095447
-
The many causes of subclinical hyperthyroidism.Thyroid. 1996 Oct;6(5):391-6. doi: 10.1089/thy.1996.6.391. Thyroid. 1996. PMID: 8936661
-
Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.J Nucl Med. 1985 Nov;26(11):1248-56. J Nucl Med. 1985. PMID: 3840528
-
Graves' disease, multinodular goiter and subclinical hyperthyroidism.Ann Endocrinol (Paris). 2019 Sep;80(4):240-249. doi: 10.1016/j.ando.2018.09.004. Epub 2018 Sep 25. Ann Endocrinol (Paris). 2019. PMID: 31427038 Review.
-
Subclinical thyrotoxicosis.Endocrinol Metab Clin North Am. 1998 Mar;27(1):37-49. doi: 10.1016/s0889-8529(05)70296-6. Endocrinol Metab Clin North Am. 1998. PMID: 9534026 Review.
Cited by
-
Stability of thyroid function in older adults: the Birmingham Elderly Thyroid Study.Br J Gen Pract. 2018 Oct;68(675):e718-e726. doi: 10.3399/bjgp18X698861. Epub 2018 Aug 28. Br J Gen Pract. 2018. PMID: 30154078 Free PMC article.
-
United detection GNAS and TSHR mutations in subclinical toxic multinodular goiter.Eur Arch Otorhinolaryngol. 2010 Feb;267(2):281-7. doi: 10.1007/s00405-009-1051-3. Eur Arch Otorhinolaryngol. 2010. PMID: 19826830
-
Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis.J Endocrinol Invest. 2020 Feb;43(2):219-229. doi: 10.1007/s40618-019-01105-7. Epub 2019 Aug 26. J Endocrinol Invest. 2020. PMID: 31452116
-
Management of subclinical hyperthyroidism.Int J Endocrinol Metab. 2012 Spring;10(2):490-6. doi: 10.5812/ijem.3447. Epub 2012 Apr 20. Int J Endocrinol Metab. 2012. PMID: 23843809 Free PMC article.
-
The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism.Eur Thyroid J. 2015 Sep;4(3):149-63. doi: 10.1159/000438750. Epub 2015 Aug 26. Eur Thyroid J. 2015. PMID: 26558232 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical